Pipeline

A paradigm shift in antibody discovery for cancer

We have developed an advanced, innovative and efficient high-throughput single B cell culturing platform to rapidly discover and generate completely human-derived, tumor-targeted recombinant antibodies for the treatment of a variety of cancers.